Nasopharyngeal Carcinoma: all 824 studies
Page 7 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical ApplicationStatus unknownNCT02980315Phase 1/2
- Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC PatientsCompletedNCT02973386Phase 3
- Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02958111Phase 3
- A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma PatientsStatus unknownNCT02948699Phase 4
- Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal CarcinomaStatus unknownNCT02945878
- Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02944708Phase 3
- TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal CarcinomaCompletedNCT02940925Phase 3
- Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal CancerStatus unknownNCT02937519Phase 2
- The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCCStatus unknownNCT02915432Phase 1/2
- Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02907710Phase 3
- A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT02878889Phase 2
- ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following RadiotherapyTerminatedNCT02874651Phase 2
- Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02871518Phase 2
- Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma PatientsStatus unknownNCT02854410Not applicable
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesNo longer availableNCT02822495
- Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal CarcinomaTerminatedNCT02801487Phase 1/2
- Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal CarcinomaCompletedNCT02795195Phase 1/2
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedNCT02789189Phase 2
- Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02786641Phase 3
- Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma PatientsCompletedNCT02776124Phase 2
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)CompletedNCT02759250Phase 1
- Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02735317Phase 2
- Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRTStatus unknownNCT02729324Phase 2
- Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal CarcinomaTerminatedNCT02698111Phase 1/2
- Post-radiation Hypothyroidism After IMRT for Nasopharyngeal CarcinomaCompletedNCT02689609
- Individualized Elective Neck Irradiation Based on MRI in NPC PatientsCompletedNCT02642107Phase 3
- Endostar for Locally Recurrent Nasopharyngeal CarcinomaStatus unknownNCT02636231Phase 2
- Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy EraCompletedNCT02633202Phase 3
- Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02633176Phase 3
- Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal CarcinomaStatus unknownNCT02627807Not applicable
- Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal CarcinomaStatus unknownNCT02621970Phase 3
- Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal CarcinomaStatus unknownNCT02610556Phase 2
- A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal CancerCompletedNCT02608073Phase 2
- Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma PatientsCompletedNCT02604472
- Nasopharyngeal Carcinoma Post IMRTActive, not recruitingNCT02597426
- A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPCStatus unknownNCT02590133Phase 2
- Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in ChinaCompletedNCT02586532
- Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyTerminatedNCT02582008Early Phase 1
- Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC PatientsCompletedNCT02575547
- Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal CarcinomaTerminatedNCT02569788Phase 1/2
- Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-CisplatinCompletedNCT02562599Phase 2
- The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownNCT02537925Phase 3
- HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal CarcinomaCompletedNCT02523430Phase 1/2
- A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal CarcinomaStatus unknownNCT02512315Phase 3
- Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
- Vestibular Function After Chemoradiotherapy for Nasopharyngeal CarcinomaStatus unknownNCT02505672
- The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC PatientsCompletedNCT02505139
- Nasopharyngeal Carcinoma Screening in Zhongshan CityActive, not recruitingNCT02501993
- Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal CarcinomaStatus unknownNCT02500940Phase 3
- Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownNCT02481089
- Serial Plasma EBV DNA for Nasopharyngeal CarcinomaStatus unknownNCT02476669
- The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRTActive, not recruitingNCT02460887Phase 3
- Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal CarcinomaCompletedNCT02460419Phase 3
- Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT02456506Not applicable
- Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02434614Phase 3
- Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPCStatus unknownNCT02421640Phase 2
- Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical PrognosisStatus unknownNCT02401763
- A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNATerminatedNCT02363400Phase 3
- Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal CarcinomaCompletedNCT02360501Phase 2
- A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal CarcinomaStatus unknownNCT02328261Phase 2
- Early Use of Opioid in Radiation MucositisCompletedNCT02309437Phase 2
- Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal CarcinomaStatus unknownNCT02301208Phase 3
- Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal CarcinomaStatus unknownNCT02293356Phase 4
- Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated RadiotherapyWithdrawnNCT02289807Not applicable
- Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02250599Phase 2
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
- Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal CarcinomaCompletedNCT02237924Phase 2
- Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal CarcinomaStatus unknownNCT02211677
- Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc TauliCompletedNCT02199132
- Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical StudyStatus unknownNCT02187315Phase 2
- Parotid-sparing IMRT for Nasopharyngeal CancerCompletedNCT02149641
- Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical TrialCompletedNCT02143388Phase 3
- Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNAActive, not recruitingNCT02135042Phase 2/3
- The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal CarcinomaStatus unknownNCT02116231Phase 2
- Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal CarcinomaCompletedNCT02113423Not applicable
- Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02111460Phase 3
- The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02096380
- Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal CarcinomaStatus unknownNCT02089204
- Nelfinavir for the Treatment of Gammaherpesvirus-Related TumorsTerminatedNCT02080416Early Phase 1
- TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPCActive, not recruitingNCT02065362Phase 1
- Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA AnalysisStatus unknownNCT02063399
- OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive ChemoradiotherapyTerminatedNCT02058017Phase 1
- Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma PatientsStatus unknownNCT02044562Not applicable
- Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid StenosisSuspendedNCT02022293Phase 2
- Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal CarcinomaStatus unknownNCT02016417Phase 2
- Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPCCompletedNCT02012062Phase 3
- Swallowing Exercises for Nasopharyngeal Cancer After Radiation TherapyCompletedNCT01937793Not applicable
- Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
- Treatment of Cerebral Radiation Necrosis With GM1, a Prospective StudyStatus unknownNCT01884987
- Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01872962Phase 3
- Effect of Edaravone on Radiation-induced Temporal Lobe NecrosisCompletedNCT01865201Phase 2
- Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPCStatus unknownNCT01854203Phase 2/3
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
- Study of DC-CIK to Treat NPCStatus unknownNCT01821495Phase 2
- The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRTStatus unknownNCT01817023Phase 3
- Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral MucositisStatus unknownNCT01806272Phase 2
- A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal CarcinomaCompletedNCT01800071Phase 1